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Abstract Germline competent embryonic stem (ES) cells can
serve as a tool to create genetically engineered rat strains used
to elucidate gene function or provide disease models. In
optimum culture conditions, ES cells are able to retain their
pluripotent state. The type of components present and their
concentration in ES cell culture media greatly influences
characteristics of ES cells including the ability to maintain
the cells in a pluripotent state. We routinely use 2i media
containing inhibitors CHIR99021 and PD0325901 to culture
rat ES cells. CHIR99021 specifically inhibits the Gsk3β path-
way.We have found that the vendor source of CHIR99021 has
a measurable influence on the level of aneuploidy seen over
time as rat ES cells are passaged. Karyotyping of three differ-
ent rat ES cell lines passaged multiple times showed increased
aneuploidy when CHIR99021 from source B was used. Mass
spectrometry analysis of this inhibitor showed the presence of
unexpected synthetic small molecules, which might directly
or indirectly cause increases in chromosome instability.
Identifying these molecules could further understanding of
their influence on chromosome stability and indicate how to
improve synthesis of this media component to prevent dele-
terious effects in culture.
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Introduction
Embryonic stem (ES) cells have the ability for continuous
self-renewal which requires the maintenance of a pluripotent
state through unique transcriptional control (Chen and Daley
2008). The pluripotency of ES cells along with the conve-
nience with which they can be manipulated genetically offers
a powerful tool to elucidate gene function or to create animal
models of disease (Li et al. 2008). The rat is a preferred animal
model in many fields of biomedical research because in part,
its larger size offers advantages over mice for physiological
and pharmacological studies (Abbott 2004). However, it has
lagged behind the mouse as a model organism because until
recently, the ability to genetically manipulate the rat genome
was limited (Li et al. 2008). With the establishment of
germline competent rat ES cells (Buehr et al. 2008; Li et al.
2008; Voigt and Serikawa 2009), it is now possible to use the
same ES cell-based techniques that have been so successful in
creating genetically altered mice to create rat models.
Germline competence of ES cells is a crucial characteristic
in the creation of genetically engineered animals. The standard
procedure to achieve germline transmission of ES cells in-
cludes injection of ES cells into host blastocysts to make
chimeric animals which are then bred to produce offsprings
that are evaluated for the presence of the genetic contribution
from the ES cell line. Aneuploid ES cells have very low rates
of germline transmission (Longo et al. 1997). Thus, it be-
comes important to have a significant number of euploid cells
during blastocyst injection to achieve efficient levels of
germline transmission.
ES cell culture is done routinely using specific growth
media which help ES cells to multiply in number while
retaining pluripotency. Media components influence the char-
acteristics of ES cells, e.g., inhibitors affect specific pathways
and keep the cells in a pluripotent state. Rat ES cells are
propagated using 2i media which contains two inhibitors: a
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MEK inhibitor, PD0325901, and the Gsk3 inhibitor,
CHIR99021. The MEK/ERK signaling pathway plays a cru-
cial role in the self-renewing state of ES cells; PD0325901
inhibitor suppresses ERK activation, thereby inhibiting ES
cell differentiation (Buehr et al. 2008; Ying et al. 2008).
Inhibition of Gsk3 helps ES cells to retain ground state via
overall reduction of biosynthetic capacity and stabilization of
β-catenin which results in stimulation of canonical Wnt sig-
naling (Anton et al. 2007; Buehr et al. 2008; Silva and Smith
2008; Meek et al. 2013). Inclusion of these inhibitors in rat ES
cell media is crucial, and therefore, the quality and concentra-
tion of these inhibitors are important parameters to control for
successful rat ES cell culture and propagation.
In the course of routine expansion of rat ES cells for
archiving cryopreserved stocks, we noted an unexpected in-
crease in aneuploidy in ES cells passaged over time. This
increased aneuploidy was linked to one component of the
media, the CHIR99021 inhibitor, and it was dependent on
the vendor source of this reagent. Further analysis suggests
that the presence of other synthetic molecules in the reagent
have a detrimental effect on chromosome stability.
Materials and Methods
Rat ES cell lines and culture procedures. Rat ES cell lines
SD.Tg.EC1 (RRRC# 561), F344.Tg.EC4011 (RRRC# 654)
and DA-EC8 (RRRC# 464) were obtained from the Rat
Resource and Research Center (University of Missouri,
Columbia, MO; www.rrrc.us). All three rat ES cell lines
were cultured using serum-free N2B27 media prepared as
described in Ying et al. 2008. CHIR99021 inhibitor was
purchased from Stemgent, Cambridge, MA (source A) or
BioVision, San Francisco, CA (source B). 2i media was
prepared by addition of final concentrations of 3 μM
CHIR99021 from either source A or B and 0.5 μM of
PD0325901 (Stemgent) to N2B27 media.
A vial of 1×106 ES cells was brought out of cryopreser-
vation and divided equally to seed two cultures which were
identical except for the source of CHIR99021 in the 2i
media. ES cells were cultured at 37°C in a CO2 incubator
maintaining 5% humidity. The feeder cells were mitotically
inactive CF-1 MEFs (Millipore, Billerica, MA) cultured
with feeder media containing 10% FBS (Hyclone,
Waltham, MA) and GMEM (Invitrogen, Carlsbad, CA).
Since rat ES cells loosely attach to feeders, ES cells were
detached from the feeders by mechanical dissociation with
gentle pipetting. Rat ES cells were passaged every 48 h
using Accutase (Sigma, St. Louis, MO) to obtain single cell
suspension after harvesting by centrifugation. The cells
were passaged at least three times after recovery from
cryopreservation and harvested when they reached
60–70% confluency before preparing metaphase spreads.
Metaphase spread preparation and Giemsa-trypsin
banding. Rat ES cells were cultured in 60 mm culture dishes
for at least three passages and plated at a 1–2 million cell
density on a 60-mm dish after the third passage.
Approximately 24 h after passaging, cells were fed with
2 ml fresh 2i media and treated with 10 μg/ml of Colcemid
(Irvine Scientific, Santa Ana, CA) for 1.5 h at 37°C. Cells
were then dissociated into single cell suspension with
Accutase and centrifuged at 150×g for 8 min in a 15-ml
conical tube to pellet the cells. The pellet was resuspended
in 4–5 ml of hypotonic solution (0.56%KCl) and incubated at
room temperature for 30 min. A few drops of freshly made
fixative consisting of 3:1 methanol:acetic acid (Fisher
Scientific, Pittsburgh, PA) were added and mixed by inver-
sion. The cells were centrifuged at 150×g for 8 min to pellet
the cells. The fixation step was repeated twice before dropping
the cells on wet microscope slides to prepare metaphase
spreads. One- or 2-d-old slides were used for Giemsa-trypsin
banding. On the day of Giemsa banding, slides were incubated
in 2X SSC at 62°C and then cooled down under tap water.
Slides were rinsed in 0.85% NaCl solution and then treated
with 0.025% trypsin (Millipore) in 0.85% NaCl for 6–8 s and
then immediately washed in 1X PBS. After dipping the slides
in Gurr’s buffer (VWR, Radnor, PA), slides were stained for
7–8 min in Giemsa stain (Gibco, Carlsbad, CA). Slides were
then visualized, and chromosomes were analyzed for abnor-
malities using ASI imaging and analysis software (Applied
Spectral Imaging, Carlsbad, CA). At least 20 cells were ex-
amined for each treatment group. The distribution of differ-
ences in euploidy levels in cells cultured with media contain-
ing either source A or source B inhibitor was analyzed by
Mixed Logistic Model with one factor.
LCMS analysis for CHIR99021 inhibitor. LCMS analysis on
CHIR99021 inhibitor from source A and source B was per-
formed at the Mass Spectrometry Facility at the University of
Missouri, Department of Chemistry. The LC system consisted
of a Thermo-Finnigan P4000 quaternary LC pump and
SCM1000 vacuum degasser, an AS3000 autosampler, and a
UV6000LP diode-array detector. The LC system was con-
nected to a Thermo-Finnigan TSQ7000 triple quadrupole
mass spectrometer equipped with an atmospheric pressure
chemical ionization (APCI) source. Separation of sample
components was accomplished using water (eluent “A”) and
acetonitrile (eluent “B”) with a gradient as follows: 0 min, 1%
“B”; 30 min, 100% “B”; 34 min, 100% “B”; 35 min, 1% “B”;
and 40 min, 1% “B”. Sample injections were 20 μL, and
samples were separated on a 4.6×250mm Prodigy ODS(3)
column with 5 μm particles (Phenomenex, Torrance, CA).
The diode array detector acquired spectra from 190 to
450 nm at a rate of 1 Hz. For the mass spectrometer, the
APCI vaporizer temperature was set at 400°C, and the dis-
charge current was 5 μA; the heated capillary was maintained
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at 250°C. Nitrogen was supplied to the source from the
headspace of a Dewar of liquid nitrogen; the sheath gas
pressure was 80 psi and the auxiliary gas flow rate was 40
(arbitrary units). Other settings were as determined during the
periodic tuning and calibration of the instrument. Spectra were
acquired every second across a scan range of m/z 100 to 800.
The same LCMS system and conditions were used for MS/
MS experiments, with the collision cell having 1 mtorr Ar and
the collision energy set at 25 eV. Only single-charged precur-
sor ions were observed; these were selected for MS/MS in the
retention time windows in which they occurred. Additional
MS/MS experiments were performed by direct infusion on a
Thermo LCQ DecaXP Plus ion trap mass spectrometer
equipped with an APCI ion source.
Results
SD.Tg.EC1 rat ES cells cultured in media with source B
inhibitor showed increased levels of aneuploidy. During rou-
tine expansion of the SD.Tg.EC1 ES cell line from a cryopre-
served, low passage (p9) stock, it was noted that the cell line,
which had a normal karyotype previously (>90% normal, data
not shown), was now showing higher than expected levels of
aneuploidy, including monosomy for Chromosome 14. A
review of our lab protocol and procedures indicated that the
only change that had occurred since the initial expansion and
cryopreservation of the low passage SD.Tg.EC1 ES cell line
was a change in vendor source for the CHIR99021 inhibitor.
Based on the manufacturers’ information, the inhibitor from
sources A (original source of inhibitor) and B (new vendor
source) has comparable composition and purity levels. We
cultured SD.Tg.EC1 cells under identical conditions except
for the source of the inhibitor added to the media. Karyotype
analysis of p16 cells (Fig. 1) indicated less euploidy in the
cells cultured in media with source B inhibitor (52% cells with
normal karyotype) than those cultured in media containing
source A inhibitor (78% cells with normal karyotype) (Fig. 2).
These observations suggest that the presence of source B
inhibitor in ES cell media results in increased levels of aneu-
ploidy in SD.Tg.EC1 cultured cells.
Use of CHIR99021 inhibitor from source A and source B
shows major difference in aneuploidy levels in different rat
ES cell lines. To investigate whether the observation of in-
creased aneuploidy was unique to the SD.Tg.EC1 cell line,
two different rat ES cell lines, F344.Tg.EC4011 (p13, 100%
normal karyotype) and DA-EC8 (p31, 72% normal karyo-
type) were tested. The cell lines are derived from different
inbred rat genetic backgrounds (Fischer 344 and Dark Agouti,
respectively) as compared to the SD.Tg.EC1 cell line which
has an outbred Sprague Dawley genetic background. In this
set of experiments, a single vial of cryopreserved cells was
evenly divided between two cultures containing 2i culture
media. The sole difference between the two cultures was the
source of the CHIR99021 inhibitor. Cells were passaged every
48 h for three passages after recovery from cryopreservation
and karyotyping with Giemsa-trypsin banding was performed
after the third passage. We did not note any overtly obvious
differences in growth, cell numbers, or see evidence of differ-
ences in cell death between source A or source B cultures.
However, we did find that there was a major difference in the
percent of cells examined with normal versus abnormal kar-
yotypes depending on whether source A or source B inhibitor
was used (Fig. 2). The percentage of euploid cells was 85%
(source A) and 29% (source B) for F344-Tg.EC4011 and 70%
(source A) and 48% (source B) for DA-EC8 (Fig. 2).
For all three lines (SD.Tg.EC1, F344.Tg.EC4011, and DA-
EC8), cells cultured in media containing source B inhibitor
had more cells with an abnormal karyotype, specifically loss
or gain of chromosomes, than the cells grown in media con-
taining source A inhibitor. No cases of polyploidy were ob-
served in any of the cultures examined. In Table 1, the total
number of cells examined from each culture grown in media
with sources A or B inhibitor is indicated, and the chromo-
some abnormalities are listed along with the number of cells
that exhibited that particular defective chromosome makeup.
DA-EC8 (p31) had overall higher levels of aneuploidy but
was also at a higher passage number when analyzed.
Liquid chromatography mass spectrometry analysis of source
A and source B CHIR99021. CHIR99021 from source B was
≥95% pure according to the datasheet provided and it was
assessed for purity with HPLC. CHIR99021 from source A
was greater than 95% pure according to HPLC, and its correct
mass was determined by mass spectrometry according to the
vendor source. In order to understand the composition of these
inhibitors, the compounds were analyzed by liquid
chromatography-mass spectrometry (LCMS) technique which
showed differences in the source A and source B compounds.
Both the compounds clearly contained inhibitor molecule
(species E) (Fig. 3). Source A inhibitor showed the presence
of the main inhibitor compound without a significant presence
of any other species. In addition to the inhibitor compound,
source B had several other compounds present which were not
seen in source A inhibitor.
Synthetic byproducts are present in source B inhibitor
compound. Three different columns and solvent systems were
tested, as well as two different ionization sources: electrospray
(ESI) and atmospheric pressure chemical ionization (APCI).
APCI provided universally better signal than ESI, although it
appears to lead to some spontaneous fragmentation (vide
infra). The signal for [M + H] + at m/z 465 was 14 times
greater with APCI despite loss of approximately 40% of the
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signal due to spontaneous fragmentation. The column and
solvent system described herein yielded the best separation,
with minimal chromatographic aberrations induced by the
sample solvent. Several significant species were observed in
the sample from source B, including CHIR99021; three of
these were observed also in the sample from source A (Fig. 3).
Details of the observed species are given in Table 2; note that
while peak areas are reported in the absence of standards the
impurities cannot be quantified with accuracy, and no attempt
is made to do so. Based on the parent ions observed and the
fragment ion spectra of those ions, possible identities for some
of the impurities are discussed below.
Species A through D. For species A, the dominant fragments
are at m/z 173/175 with an isotope pattern indicating two
chlorine atoms, which is a 2,4-dichlorophenylcarbonyl moie-
ty; the data is insufficient to conclude anything other than that
this species arises from improper linkage or possibly
inadequate cleanup of products early in the synthesis. For
species B, a fragment at m/z 146 is present (arising from the
cyanopyridyl end of the molecule), but chlorine is absent. The
mass difference between this and CHIR99021 can be ex-
plained by absence of the dichlorophenyl moiety. In 2 of
Fig. 4, the postulated structure was shown. For species C,
the diagnostic fragment at m/z 146 is absent, indicating an
absence of the cyanopyridyl end of the molecule; the mass
difference is consistent with such an absence, and the structure
is shown in 3 of Fig. 4. For species D, the most abundant
fragment ion is m/z 175, arising from loss of neutral dichlo-
robenzene from the parent ion; this is followed by neutral loss
of CO and, subsequently, HCN to give a fragment at m/z 120.
Based on this, we theorize the structure in 4 of Fig. 4 for this
analyte.
Species E–H. Species E shown in 1 of Fig. 4 is intact
CHIR99021. It appears to undergo a significant degree of
Figure 1. Karyotype analysis. SD-Tg.EC1, p16 metaphase chromo-
somes were stained with Giemsa-trypsin. a Cells cultured in media
containing source A CHIR99021 have a normal karyotype (42, XY).
b Cells cultured in media containing source B CHIR99021 have an
abnormal karyotype (41, XY, −14). n=20 metaphase spreads ana-
lyzed per culture.
Figure 2. Percent of euploidy in three separate rat ES cell lines
cultured with media containing either source A (black) or source B
(gray) CHIR99021 inhibitor. The probability of having a normal
chromosome number in cells treated with culture media containing
source A is significantly higher than for cells treated with culture
media containing source B for all three cell lines (p<0.0001).
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in-source fragmentation due to the temperature and/or chemis-
try of the ion source; observed fragments in the LCMS data
include m/z 429/431 (loss of HCl), m/z 320/322 (loss of the
cyanopyridyl moiety),m/z 310/312 (loss of cyanopyridylamine
from the fragment at m/z 429/431), m/z 284/286 (loss of
HCl from the fragment at m/z 320/322), and m/z 146
(a cyanopyridylaminoethyl group, which turns out to be a
diagnostic fragment for the presence of this moiety). Species
F is greater in mass than CHIR99021 by 14 Da but has a very
similar fragmentation pattern and appears to be identical to
CHIR99021 save for an extra methylene in an undetermined
location on the dichlorophenyl end of the molecule. Species G
yields the diagnostic fragment at m/z 146 (inclusion of the
cyanopyridyl moiety) but is otherwise of uncertain structure.
Species H1 and H2 have the same fragment ion spectra, which
are identical to the fragmentation of CHIR99021 following its
initial loss of HCl; these apparently isomeric species seem to
arise from condensed phase loss of HCl whether during the
synthesis or storage is uncertain.
There are numerous other less abundant species present,
most being too weak for reliable MS/MS but some having the
recognizable chlorine isotope pattern and the fragment ion at
m/z 146 which indicates the presence of the cyanopyridyl
group. Although most of the impurities are not identified
and none of them are quantified, the important observation
is that various impurities structurally similar to CHIR99021
are present and are believed to give rise to chromosomal
abnormalities in the ES cell culture experiments.
Table 1 Chromosomal abnormalities observed in cultures
F344.Tg.EC4011 (p13) DA-EC8 (p31) SD.Tg.EC1 (p16)
Source A (n=26) Source B (n=21) Source A (n=23) Source B (n=29) Source A (n=41) Source B (n=36)
−13 (n=1) −13 (n=7) −13 (n=1) −5 (n=1) −14 (n=5) −14 (12)
−19 (n=2) −10, 13 (n=1) −19 (n=1) −13 (n=4) −10, 14 (n=1) −9, 14 (n=1)
−8, 10, 14 (n=1) −13, 15 (n=3) −10, 19 (n=1) −15 (n=2) +9 (n=2) +15 (n=1)
−8, 14 (n=1) −5, 13, 15 (n=1) −5, 15 (n=1) +19 (n=1) +19 (n=3)
−8, 12,13 (n=1) −10, 13, 19 (n=1) −13, 19 (n=1)
+18 (n=2) +15 (n=1) −8, 13, 15 (n=1)
+19 (n=1) −2, 13, 15, 19 (n=1)
−5, 6, 13, 16, 20 (n=1)
+19 (n=2)
+9, 16 (n=1)
Figure 3. Chromatograms (λ=340 nm) for samples from sources A and
B; outside the retention times shown here, only the background signal is
observed. The chromatogram for source B has been scaled so that the
major peak approximates the magnitude of the same peak for source A.
Peak labels correspond to the data in Table 2.
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Discussion
The derivation of rat ES cells has become an important tool in
the application of gene targeting and related technologies for
many aspects of biomedical research (Buehr et al. 2008). Rat
ES cell culture is carried out routinely in various laboratories.
After derivation of a rat ES cell line, cells are passaged to
expand the line and also to avoid differentiation by over-
crowding of ES colonies. It is well-established that ES cells
from many species, including rat, are reasonably stable at
early passage numbers, but chromosomal abnormalities in-
crease with higher passages (Liu et al. 1997; Li et al. 2008;
Narva et al. 2010). If injected into blastocysts, these ES cells
frequently result in chimeric animals that do not demonstrate
germline transmission of the genetic contribution of the ES
cells (Fedorov et al. 1997; Longo et al. 1997). In our study, we
show that by using CHIR99021 from source B, the number of
aneuploid cells increased considerably in three different rat ES
cell lines even at lower passages.
Rat media consists of several components each having
unique and important functions in maintaining pluripotency
and overall viability with cell growth (Ying et al. 2008). To
sustain efficient ES cell self-renewal, CHIR99021 inhibitor
(Ying et al. 2008) is used with PD0325901 inhibitor (Bain
et al. 2007) at very specific concentrations in ES cell media. A
higher dose of PD0325901 causes suppression of ERK acti-
vation causing growth arrest and cell death but with addition
of CHIR99021 which down-modulates Gsk3; the combina-
tion of these two inhibitors maintains metabolic activity, bio-
synthetic capacity, and overall viability (Ying et al. 2008).
This crucial role of inhibitors shows that concentrations of
individual components in ES cell media are critical to main-
tain ES cell characteristics. Any change in their concentrations
can cause unwanted side effects in ES cell culture.
Genome stability requires that replicated chromosomes are
accurately segregated during mitosis (Nicklas 1997).
Chromosome segregation is facilitated by a microtubule spin-
dle, where chromosomes attach via their kinetochores,
Table 2 Significant chemical
species observed in LCMS data
for CHIR99021 from source B




23.60 A 296/298 2 173/175 2.6
24.95 B 321 0 146 21.6
25.42 C 320/322 2 – 1.4
27.75 D 321/323 2 175, 147, 120 36.7
32.95 E 465/467 2 146 1742
34.35 F 479/481 2 146 114.8
35.90 G 466/468 2 146 23.7
38.80 H1 429/431 1 146 27.1
39.15 H2 429/431 1 146 17.7
Figure 4. Structures for some of
the observed species: (1)
CHIR99021, (2) species B, (3)
species C, and (4) species D.
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complex microtubule-binding structures which assemble at
the centromeric heterochromatin (Cleveland et al. 2003;
Maiato et al. 2004; Chan et al. 2005). Cells treated with
Gsk3 inhibitors frequently show abnormal spindle morpholo-
gy with elevated numbers of astral microtubules, and thus in
cultured cells, Gsk3 inhibitors induce chromosome non-
disjunction which may cause unexpected induction of chro-
mosome instability (Tighe et al. 2007).
In our study, we found that three different rat ES cell lines
derived from different rat strains/stocks and at different pas-
sage numbers (relatively low for SD.Tg.EC1 and
F344.Tg.EC4011 while relatively high for DA-EC8) showed
greatly increased aneuploidy when treated with source B
CHIR99021 inhibitor while remaining relatively stable in
the presence of source A CHIR99021.
Based on the abnormal karyotypes seen, it is possible that
many of the abnormal cells are showing accumulation of non-
disjunction events in each successive passage, for example, in
the F344-Tg.EC4011 cell line grown in media containing
source B inhibitor, monosomy 13 was seen in 29% of the
abnormal cells with other abnormal cells showing loss of anoth-
er Chromosome (10 or 15) in addition to loss of Chromosome
13. Loss of Chromosome 13was themost common abnormality
for both F344-Tg.EC4011 and DA-EC8 regardless of the source
of inhibitor. Although no single Chromosome was selectively
lost in the cells from all three different cell lines, loss or gain of
Chromosomes 19 was found in all three. Observations of kar-
yotypic abnormalities preferentially involving a particular
Chromosome have been noted in mouse ES cells, where, in
surveys of mouse ES cell lines, trisomy 8 often predominates
(Liu et al. 1997; Sugawara et al. 2006).
Interestingly, SD.Tg.EC1 seemed particularly prone to
Chromosome 14 monosomy. This cell line was derived from
the SD-Tg(UBC-EGFP)2BalRrrc (RRRC#065) rat strain and
is hemizygous for a single EGFP transgene whose insertion
site is on Chromosome 14 (Bryda et al. 2006; Men et al.
2012). The fact that Chromosome 14 seemed to be selectively
lost suggests the presence of the transgene may impact proper
chromosomal segregation, especially under conditions (in-
creased Gsk3 inhibition) that are leading to increased non-
disjunction.
The LCMS analysis of source B inhibitor showed the
presence of small synthetic molecules which resemble
byproducts of synthesis and/or purification of CHIR99021
and also fragments of the main inhibitor molecule. We spec-
ulate that the presence of these byproducts actually results in
increased bioactivity of this compound. In essence, the
amount of inhibitor is greater than expected which leads to
an increase in downstream effects on chromosome stability.
This, in turn, increases the level of aneuploidy in ES cell
culture. Additionally, it has been reported recently that when
the amount of Gsk3 inhibitor CHIR99021 was decreased from
3.0 to 1 μM in the media of cultured rat embryonic stem cells
(ESCs), less differentiation occurred (Chen et al. 2013).
Therefore, unrecognized elevated bioactivity in CHIR99021
from different vendor sources could also negatively impact rat
ESC cell self-renewal and increase unwanted differentiation.
Conclusion
Rat ES cell culture media greatly influences the characteristics
of rat ES cells and one important characteristic necessary for
successful use of ES cells for genetic manipulation is the
presence of normal karyotypes in the majority of the cells.
While conducting routine rat ES cell culture in our lab, we
observed increased levels of aneuploidy in rat ES cells when
the media contained source B inhibitor which we chose over
the previous source A inhibitor for its comparable purity and
lower cost. Our analysis of LCMS experiments showed the
presence of small synthetic molecules in source B inhibitor
which are absent in source A inhibitor. We suspect that these
small synthetic molecule species are a result of either the
synthesis and/or purification process. We speculate that the
presence of these synthetic molecules alters the effective
concentration of bioactive Gsk3 inhibitor, contributing to the
higher aneuploidy levels in rat ES cells. This study is a
cautionary tale emphasizing the importance of documenting
the source of all reagents and carefully assessing their impact
by routine quality control measures.
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